Institutional Review Board (IRB of the Egyptian National Cancer Institute (ENCI)
Mission
The primary mission of the Institutional Review Board (IRB) is to protect the rights, welfare and privacy of all individuals participating in biomedical, social, and behavioral research activities, including field or off-site research, as conducted by NCI-Egypt faculty, staff, and students.
The IRB conducts reviews of proposed research studies employing an assessment process that determines that the methodology used is consistent with sound research design and that the risk to participants/subjects is minimized. The IRB also provides
interpretive assistance and support to the research community.
IRB Overview
The Egyptian National Cancer Institute (NCI-Egypt) has a Federal-wide Assurance (FWA) with
the Office of Human Research Protection (OHRP) in the Department of Health and Human
Services (DHHS). In the FWA, the Institutional Official, that is the NCI-Egypt Vice Dean for
Research (and Post-graduate Education) (VDR), certifies that NCI-Egypt assures that all
activities related to human subjects’ research, regardless of the funding source, are guided by
the ethical principles of the Declaration of Helsinki and the Belmont Report. In addition,
research sponsored by National or other funding agencies must abide by their corresponding
regulations. Under the umbrella of the NCI-Egypt, the Institutional Review Board (IRB) is
charged with the prior review and approval of all research involving human participants at
ENCI and other research sites, unless the research was granted an exempt from IRB review
status, upon review of submitted relevant information.
